Clinical Trial Update: Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 exploratory trial of topical norepinephrine in breast cancer patients undergoing radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiodermatitis

Drugs mentioned

• Topical norepinephrine (norepinephrine)

Snippet

Sponsor: ProCertus BioPharm, Inc | Conditions: Radiodermatitis | Phase 1, Phase 2 | Status: WITHDRAWN